Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod

被引:0
|
作者
Rocco Capuano
Manuela Altieri
Miriana Conte
Alvino Bisecco
Alessandro d’Ambrosio
Giovanna Donnarumma
Elena Grimaldi
Nicola Coppola
Nicola Medici
Massimiliano Galdiero
Gioacchino Tedeschi
Antonio Gallo
机构
[1] University of Campania “Luigi Vanvitelli”,Department of Advanced Medical and Surgical Sciences (DAMSS)
[2] AOU San Giovanni and Ruggi,Department of Medical Sciences, Neurology Unit
[3] University of Campania “Luigi Vanvitelli”,Department of Experimental Medicine
[4] University of Campania “Luigi Vanvitelli”,Department of Mental Health and Public Medicine
[5] University of Campania “Luigi Vanvitelli”,Department of Precision Medicine
来源
Journal of Neurology | 2022年 / 269卷
关键词
Booster dose; BNT162b2 mRNA vaccine; Ocrelizumab; Fingolimod; COVID-19;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:6185 / 6192
页数:7
相关论文
共 50 条
  • [1] Humoral response and safety of the third booster dose of BNT162b2 mRNA COVID-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
    Capuano, Rocco
    Altieri, Manuela
    Conte, Miriana
    Bisecco, Alvino
    D'Ambrosio, Alessandro
    Donnarumma, Giovanna
    Grimaldi, Elena
    Coppola, Nicola
    Medici, Nicola
    Galdiero, Massimiliano
    Tedeschi, Gioacchino
    Gallo, Antonio
    [J]. JOURNAL OF NEUROLOGY, 2022, 269 (12) : 6185 - 6192
  • [2] Safety and efficacy of a third booster dose of BNT162b2 mRNA Covid-19 vaccine in patients with multiple sclerosis treated with ocrelizumab or fingolimod
    Capuano, R.
    Altieri, M.
    Conte, M.
    Bisecco, A.
    d'Ambrosio, A.
    Donnarumma, G.
    Grimaldi, E.
    Coppola, N.
    Galdiero, M.
    Abbondanza, C.
    Tedeschi, G.
    Gallo, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 769 - 769
  • [3] Humoral Response to the Third Dose of BNT162b2 COVID-19 Vaccine among Hemodialysis Patients
    Agur, Timna
    Zingerman, Boris
    Ben-Dor, Naomi
    Alkeesh, Weaam
    Steinmetz, Tali
    Rachamimov, Ruth
    Korzets, Asher
    Rozen-Zvi, Benaya
    Herman-Edelstein, Michal
    [J]. NEPHRON, 2023, 147 (3-4) : 185 - 192
  • [4] Safety and Efficacy of a Third Dose of BNT162b2 Covid-19 Vaccine
    Moreira, Edson D., Jr.
    Kitchin, Nicholas
    Xu, Xia
    Dychter, Samuel S.
    Lockhart, Stephen
    Gurtman, Alejandra
    Perez, John L.
    Zerbini, Cristiano
    Dever, Michael E.
    Jennings, Timothy W.
    Brandon, Donald M.
    Cannon, Kevin D.
    Koren, Michael J.
    Denham, Douglas S.
    Berhe, Mezgebe
    Fitz-Patrick, David
    Hammitt, Laura L.
    Klein, Nicola P.
    Nell, Haylene
    Keep, Georgina
    Wang, Xingbin
    Koury, Kenneth
    Swanson, Kena A.
    Cooper, David
    Lu, Claire
    Tuereci, Oezlem
    Lagkadinou, Eleni
    Tresnan, Dina B.
    Dormitzer, Philip R.
    Sahin, Ugur
    Gruber, William C.
    Jansen, Kathrin U.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2022, 386 (20): : 1910 - 1921
  • [5] Cellular and humoral response to the fourth BNT162b2 mRNA COVID-19 vaccine dose in patients with CLL
    Benjamini, Ohad
    Gershon, Rotem
    Bar-Haim, Erez
    Lustig, Yaniv
    Cohen, Hila
    Doolman, Ram
    Kedmi, Meirav
    Ribakovsky, Elena
    Kneller, Abraham
    Hod, Tammy
    Erez, Noam
    Levy, Itzhak
    Rahav, Galia
    Avigdor, Abraham
    [J]. EUROPEAN JOURNAL OF HAEMATOLOGY, 2023, 110 (01) : 99 - 108
  • [6] Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
    Manuela Altieri
    Rocco Capuano
    Miriana Conte
    Giovanna Donnarumma
    Elena Grimaldi
    Nicola Coppola
    Massimiliano Galdiero
    Alessandro d’Ambrosio
    Gioacchino Tedeschi
    Antonio Gallo
    [J]. Neurological Sciences, 2022, 43 : 2947 - 2949
  • [7] Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
    Altieri, Manuela
    Capuano, Rocco
    Conte, Miriana
    Donnarumma, Giovanna
    Grimaldi, Elena
    Coppola, Nicola
    Galdiero, Massimiliano
    D'Ambrosio, Alessandro
    Tedeschi, Gioacchino
    Gallo, Antonio
    [J]. NEUROLOGICAL SCIENCES, 2022, 43 (05) : 2947 - 2949
  • [8] Self Reported and Physiologic Reactions to Third BNT162b2 mRNA COVID-19 (Booster) Vaccine Dose
    Mofaz, Merav
    Yechezkel, Matan
    Guan, Grace
    Brandeau, Margaret L.
    Patalon, Tal
    Gazit, Sivan
    Yamin, Dan
    Shmueli, Erez
    [J]. EMERGING INFECTIOUS DISEASES, 2022, 28 (07) : 1375 - 1383
  • [9] Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy
    Firinu, Davide
    Fenu, Giuseppe
    Sanna, Giuseppina
    Costanzo, Giulia A.
    Perra, Andrea
    Campagna, Marcello
    Littera, Roberto
    Locci, Carlotta
    Marongiu, Alessandra
    Cappai, Riccardo
    Melis, Maurizio
    Orru, Germano
    Del Giacco, Stefano
    Coghe, Ferdinando
    Manzin, Aldo
    Chessa, Luchino
    [J]. JOURNAL OF AUTOIMMUNITY, 2022, 131
  • [10] Serological response to a third booster dose of BNT162b2 COVID-19 vaccine among seronegative cancer patients
    Shmueli, Einat Shacham
    Lawrence, Yaacov R.
    Rahav, Galia
    Itay, Amit
    Lustig, Yaniv
    Halpern, Naama
    Boursi, Ben
    Margalit, Ofer
    [J]. CANCER REPORTS, 2022, 5 (08)